A Randomized, Double-Blind, Placebo Controlled Trial examining the Safety and Efficacy of Midazolam Intranasal Spray (USL 261)for the Treatment of intermittent Bouts of Inc. Seizure Activity in the Epilepsy Monitering Unit.

Administered By

Awarded By

Contributors

Start/End

  • February 1, 2014 - August 1, 2016